Photocure ASA will announce the first quarter 2023 financial results on Wednesday 10 May 2023 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.
Photocure ASA: Invitation to presentation of first quarter 2023 financial results Read More »
Innate Pharma SA announced three abstracts including Innate’s product candidates have been accepted for the American Society for Clinical Oncology 2023 Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One abstract for SAR’579, currently developed by Sanofi, has been selected for oral presentation.
Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting Read More »
Lytix Biopharma AS is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, will give an oral presentation at the `Frontiers in Cancer Immunotherapy 2023′ conference, which is taking place in New York, USA.
Sensorion announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 24, 2023, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France.
IRLAB Therapeutics AB announced that IRLAB has been made aware that Ipsen’s 2022 Universal Registration Document, published on April 6, 2023, contains incorrect information that the development and commercialization rights for mesdopetam have been transferred back to IRLAB.
Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.
IRLAB Therapeutics AB announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January-March 2023.
IRLAB: Invitation to the Interim Report for Q1 2023 Presentation and Webcast Read More »
Innate Pharma SA, announced that the Company will hold a conference call on Wednesday, May 10, 2023 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2023.
Innate Pharma Announces Conference Call and Webcast for Q1 Business Update Read More »
Lannett Company, Inc. announced that it and certain of its subsidiaries have commenced prepackaged Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware to effectuate the transactions contemplated by the Restructuring Support Agreement announced on May 1, 2023.
Skyline Therapeutics announced multiple data presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting in Los Angeles, CA, May 16-20, 2023.
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting Read More »
